These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8098220)

  • 1. Beta adrenoreceptor subtype cross regulation in the human heart.
    Hall JA; Ferro A; Dickerson JE; Brown MJ
    Br Heart J; 1993 Apr; 69(4):332-7. PubMed ID: 8098220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective study of the effects of prolonged timolol therapy on alpha- and beta-adrenoceptor and angiotensin II receptor mediated responses in normal subjects.
    Ferro A; Hall JA; Dickerson JE; Brown MJ
    Br J Clin Pharmacol; 1997 Mar; 43(3):301-8. PubMed ID: 9088585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo demonstration of cardiac beta 2-adrenoreceptor sensitization by beta 1-antagonist treatment.
    Hall JA; Petch MC; Brown MJ
    Circ Res; 1991 Oct; 69(4):959-64. PubMed ID: 1682065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A metabolic assessment of the beta 1 selectivity of bisoprolol.
    Haffner CA; Horton RC; Lewis HM; Hughes B; Kendall MJ
    J Hum Hypertens; 1992 Oct; 6(5):397-400. PubMed ID: 1361206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of beta-adrenoreceptor antagonists on central and peripheral blood pressure at rest and during exercise.
    Cockburn JA; Brett SE; Guilcher A; Ferro A; Ritter JM; Chowienczyk PJ
    Br J Clin Pharmacol; 2010 Apr; 69(4):329-35. PubMed ID: 20406217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The beta-adrenoceptor subtype(s) mediating adrenaline- and dobutamine-induced blood pressure and heart rate changes in healthy volunteers.
    Daul A; Hermes U; Schäfers RF; Wenzel R; von Birgelen C; Brodde OE
    Int J Clin Pharmacol Ther; 1995 Mar; 33(3):140-8. PubMed ID: 7599912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of beta-adrenergic receptor blockade after isamoltane, a 5-HT1-receptor active compound, in healthy volunteers.
    Bauer K; Dietersdorfer F; Kaik G
    Clin Pharmacol Ther; 1993 Jun; 53(6):675-83. PubMed ID: 8099863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cardioselective and hypotensive effects of bisoprolol in hypertensive asthmatics.
    Chatterjee SS
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S74-7. PubMed ID: 2439803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nature of the beta-adrenoreceptor controlling plasma renin activity in man.
    Johnson BF; Smith IK; LaBrooy J; Bye C
    Clin Sci Mol Med Suppl; 1976 Dec; 3():113s-115s. PubMed ID: 192510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intracoronary injections of salbutamol demonstrate the presence of functional beta 2-adrenoceptors in the human heart.
    Hall JA; Petch MC; Brown MJ
    Circ Res; 1989 Sep; 65(3):546-53. PubMed ID: 2548759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for altered alpha-adrenoreceptor responsiveness after a single bout of maximal exercise.
    Convertino VA
    J Appl Physiol (1985); 2003 Jul; 95(1):192-8. PubMed ID: 12679359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic, electrocardiographic, and hemodynamic responses to increased circulating adrenaline: effects of selective and nonselective beta adrenoceptor blockade.
    Hansen O; Johansson BW; Nilsson-Ehle P
    Angiology; 1990 Mar; 41(3):175-88. PubMed ID: 1968731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisoprolol-based
    Kang J; More KN; Pyo A; Jung Y; Kim DY; Chang DJ
    Bioorg Med Chem Lett; 2021 Mar; 36():127789. PubMed ID: 33453362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of 2 beta-receptor blocking agents on the microcirculation of healthy subjects and of hypertensive patients.
    Albrecht M; Haustein KO
    Int J Clin Pharmacol Ther; 1997 Dec; 35(12):580-6. PubMed ID: 9455718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single dosing comparison of the relative cardiac beta 1/beta 2 activity of inhaled fenoterol and salbutamol in normal subjects.
    Newnham DM; Wheeldon NM; Lipworth BJ; McDevitt DG
    Thorax; 1993 Jun; 48(6):656-8. PubMed ID: 8102213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bisoprolol: a review of its use in chronic heart failure.
    McGavin JK; Keating GM
    Drugs; 2002; 62(18):2677-96. PubMed ID: 12466013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the effects of nadolol and bisoprolol on noradrenaline-evoked venoconstriction in man in vivo.
    Abdelmawla AH; Langley RW; Szabadi E; Bradshaw CM
    Br J Clin Pharmacol; 1998 Mar; 45(3):271-6. PubMed ID: 9517371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential haemodynamic effects induced by beta 1-(bisoprolol) or beta 2-(ICI 118,551) adrenoceptor blockade in man.
    Daul A; Johnston T; Reher M; Krüger M; Brodde OE
    J Hypertens Suppl; 1986 Dec; 4(6):S99-102. PubMed ID: 2886573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and extrapulmonary beta 2 adrenoceptor activity of nebulised racemic salbutamol and its R and S isomers in healthy volunteers.
    Lipworth BJ; Clark DJ; Koch P; Arbeeny C
    Thorax; 1997 Oct; 52(10):849-52. PubMed ID: 9404370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a mononitrate, a beta1-blocker and a dihydropyridine calcium channel blocker on cardiovascular responsiveness to passive orthostasis: a placebo-controlled double-blind study in normotensive volunteers.
    Ylitalo R; Kähönen M; Nieminen T; Kööbi T; Ylitalo P; Turjanmaa V
    Arzneimittelforschung; 2005; 55(3):160-6. PubMed ID: 15819388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.